| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
26,450 |
17,695 |
$2.96M |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
18,455 |
11,889 |
$1.73M |
| 90837 |
Psychotherapy, 53 minutes with patient |
9,893 |
5,385 |
$940K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
17,962 |
12,356 |
$800K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
11,439 |
7,788 |
$526K |
| H0006 |
Alcohol and/or drug services; case management |
20,637 |
14,597 |
$495K |
| T1002 |
Rn services, up to 15 minutes |
18,108 |
12,408 |
$495K |
| H0048 |
Alcohol and/or other drug testing: collection and handling only, specimens other than blood |
33,339 |
23,298 |
$469K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
3,141 |
2,279 |
$433K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,353 |
3,176 |
$343K |
| T1003 |
Lpn/lvn services, up to 15 minutes |
13,776 |
10,247 |
$313K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
2,089 |
625 |
$281K |
| H2036 |
Alcohol and/or other drug treatment program, per diem |
1,097 |
95 |
$223K |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
11,439 |
721 |
$191K |
| 90791 |
Psychiatric diagnostic evaluation |
1,072 |
1,005 |
$114K |
| H0020 |
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
6,836 |
992 |
$106K |
| J0575 |
Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine |
6,514 |
398 |
$86K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
489 |
435 |
$75K |
| 99215 |
Prolong outpt/office vis |
401 |
245 |
$63K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,162 |
648 |
$55K |
| 90834 |
Psychotherapy, 45 minutes with patient |
765 |
629 |
$54K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
846 |
583 |
$16K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
221 |
153 |
$16K |
| 90832 |
Psychotherapy, 30 minutes with patient |
302 |
240 |
$16K |
| 99205 |
Prolong outpt/office vis |
61 |
60 |
$11K |
| 81025 |
|
1,697 |
1,239 |
$7K |
| 80305 |
|
2,523 |
1,183 |
$5K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
82 |
71 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
82 |
71 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
82 |
71 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
82 |
71 |
$2K |
| 99201 |
|
16 |
15 |
$666.67 |
| 82075 |
|
15 |
14 |
$259.88 |
| 90785 |
|
113 |
81 |
$140.88 |
| 86780 |
|
65 |
65 |
$5.46 |